One Judge in Boston Freezes the Vaccine Reform Agenda, and HHS Takes the Fight to Appeal
A federal judge blocked Kennedy's ACIP appointees and voided the panel's votes, setting up a landmark battle over who really controls American vaccine policy.

The medical establishment could not win the argument at HHS, so it went to court. In March, US District Judge Brian Murphy of the District of Massachusetts handed the American Academy of Pediatrics and its allies a sweeping victory, blocking 13 of Secretary Robert F. Kennedy Jr.'s appointees to the CDC vaccine advisory committee and invalidating the votes the reconstituted panel had taken.
The March 16 ruling erased the panel's decisions to downgrade the hepatitis B birth dose recommendation and to narrow COVID vaccine recommendations. Murphy also found the CDC exceeded its authority when it reduced the childhood vaccination schedule from 17 diseases to 11 without consulting the committee.
The judge's legal hook was the Federal Advisory Committee Act's fair balance requirement. By his count, only 6 of the 15 members had meaningful vaccine expertise, and he concluded that a committee of nonexperts could not embody the fairly balanced points of view the law demands.
Think about that standard for a moment. For decades, ACIP was stocked with figures deeply embedded in the vaccine enterprise, and no federal judge ever found the balance lacking when skeptical voices were shut out entirely. Balance, it seems, only becomes a legal emergency when it tilts away from the industry's preferred experts.
The administration is not backing down. HHS filed an appeal in late April seeking to overturn the ruling that stalled much of Kennedy's vaccine agenda. The case now becomes a landmark test of whether an elected administration's health officials or the courts, prodded by the medical guilds, set immunization policy.
The plaintiffs cast the stakes in apocalyptic terms. AAP President Susan Kressly said the vaccine infrastructure was threatened, and public health researcher Noel Brewer said the ruling put public health back on the right path. Meanwhile the policies protected by the ruling, including newborn hepatitis B vaccination and access through the Vaccines for Children program, remain in place while the appeal proceeds.
This outlet does not give medical advice, and families should make vaccine decisions with their own doctors. But readers should be clear eyed about what is happening: a single district judge in Boston, at the request of professional associations with deep ties to the pharmaceutical economy, froze reforms voted on by a duly appointed federal advisory panel. Whichever side of the vaccine debate you occupy, government by injunction should worry you.
The appeal will decide more than a committee roster. It will decide whether vaccine policy can ever be reformed from within, or whether the old consensus is legally untouchable.
Sources
Questions readers ask
What is Media Mogul News?
Media Mogul News is an independent, reader-supported news site led by Chief Editor Nate Jurewicz. We cover the stories corporate media skips: political corruption, Big Pharma, the deep state, election integrity, cannabis freedom, crypto and the money behind all of it.
What is your political stance?
We are pro-liberty, pro-cannabis, anti-war and anti-corruption, and we hold both parties to the same standard. We are not a party outlet. When the people we agree with get something wrong, we say so.
How is Media Mogul funded?
By readers. We take no pharmaceutical advertising and no money from the industries we cover. Support comes from newsletter readers, donations and Media Mogul merchandise.
